BFPET Phase II Trials Commence – Analyst Blog

By | January 3, 2013
0 Comment

BFPET Phase II Trials Commence By Brian Marckx, CFA FluoroPharma (OTC BB: FPMI ) announced today that Phase II trials for its novel imaging agent BFPET have now commenced and are

Visit link:
BFPET Phase II Trials Commence – Analyst Blog

Related posts:

  1. Meridien Completes Beta Trials – Analyst Blog
  2. Phase III Data on Novartis’ RLX030 – Analyst Blog
  3. Ironwood Anxiety Drug in Phase I – Analyst Blog
  4. Amazon's Investment Phase Continues – Analyst Blog